Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-28 · accession 0001127602-23-007930 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-01 | 2023-02-28 | LXRX | McDermott Wendy | VP, Human Resources | M - OptEx | — | +18.9K | 18.9K | New | — |
| D | 2023-03-01 | 2023-02-28 | LXRX | McDermott Wendy | VP, Human Resources | F - Tax | $2.17 | -6,465 | 12.5K | -34% | -$14.0K |
| D | 2023-03-01 | 2023-02-28 | LXRX | McDermott Wendy | VP, Human Resources | M - OptEx | — | -18.9K | 37.9K | -33% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | M | A | 18,943 | — | 18,943 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2023-02-28 | F | D | 6,465 | $2.17 | 12,478 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 18,943 | — | 37,887 | D | — · — to — | 18,943 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |